Markowitz SD - Search Results

1

Identifying DNA methylation biomarkers for non-endoscopic detection of Barrett's esophagus.

Moinova HR, LaFramboise T, Lutterbaugh JD, Chandar AK, Dumot J, Faulx A, Brock W, De la Cruz Cabrera O, Guda K, Barnholtz-Sloan JS, Iyer PG, Canto MI, Wang JS, Shaheen NJ, Thota PN, Willis JE, Chak A, Markowitz SD. Moinova HR, et al. Among authors: markowitz sd. Sci Transl Med. 2018 Jan 17;10(424):eaao5848. doi: 10.1126/scitranslmed.aao5848. Sci Transl Med. 2018. PMID: 29343623 Free PMC article.

2

Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability.

Markowitz S, Wang J, Myeroff L, Parsons R, Sun L, Lutterbaugh J, Fan RS, Zborowska E, Kinzler KW, Vogelstein B, et al. Markowitz S, et al. Science. 1995 Jun 2;268(5215):1336-8. doi: 10.1126/science.7761852. Science. 1995. PMID: 7761852

3

A benign cultured colon adenoma bears three genetically altered colon cancer oncogenes, but progresses to tumorigenicity and transforming growth factor-beta independence without inactivating the p53 tumor suppressor gene.

Markowitz SD, Myeroff L, Cooper MJ, Traicoff J, Kochera M, Lutterbaugh J, Swiriduk M, Willson JK. Markowitz SD, et al. J Clin Invest. 1994 Mar;93(3):1005-13. doi: 10.1172/JCI117048. J Clin Invest. 1994. PMID: 8132740 Free PMC article.

4

Diverse hypermutability of multiple expressed sequence motifs present in a cancer with microsatellite instability.

Eshleman JR, Markowitz SD, Donover PS, Lang EZ, Lutterbaugh JD, Li GM, Longley M, Modrich P, Veigl ML, Sedwick WD. Eshleman JR, et al. Among authors: markowitz sd. Oncogene. 1996 Apr 4;12(7):1425-32. Oncogene. 1996. PMID: 8622858

5

Increased transversions in a novel mutator colon cancer cell line.

Eshleman JR, Donover PS, Littman SJ, Swinler SE, Li GM, Lutterbaugh JD, Willson JK, Modrich P, Sedwick WD, Markowitz SD, Veigl ML. Eshleman JR, et al. Among authors: markowitz sd. Oncogene. 1998 Mar 5;16(9):1125-30. doi: 10.1038/sj.onc.1201629. Oncogene. 1998. PMID: 9528854

6

Biallelic inactivation of hMLH1 by epigenetic gene silencing, a novel mechanism causing human MSI cancers.

Veigl ML, Kasturi L, Olechnowicz J, Ma AH, Lutterbaugh JD, Periyasamy S, Li GM, Drummond J, Modrich PL, Sedwick WD, Markowitz SD. Veigl ML, et al. Among authors: markowitz sd. Proc Natl Acad Sci U S A. 1998 Jul 21;95(15):8698-702. doi: 10.1073/pnas.95.15.8698. Proc Natl Acad Sci U S A. 1998. PMID: 9671741 Free PMC article.

7

Mutant K-ras oncogenes in colon cancers Do not predict Patient's chemotherapy response or survival.

Markowitz S, Hines JD, Lutterbaugh J, Myeroff L, Mackay W, Gordon N, Rustum Y, Luna E, Kleinerman J. Markowitz S, et al. Clin Cancer Res. 1995 Apr;1(4):441-5. Clin Cancer Res. 1995. PMID: 9816002

8

Mutational inactivation of transforming growth factor beta receptor type II in microsatellite stable colon cancers.

Grady WM, Myeroff LL, Swinler SE, Rajput A, Thiagalingam S, Lutterbaugh JD, Neumann A, Brattain MG, Chang J, Kim SJ, Kinzler KW, Vogelstein B, Willson JK, Markowitz S. Grady WM, et al. Cancer Res. 1999 Jan 15;59(2):320-4. Cancer Res. 1999. PMID: 9927040

9

Methylation of the CDH1 promoter as the second genetic hit in hereditary diffuse gastric cancer.

Grady WM, Willis J, Guilford PJ, Dunbier AK, Toro TT, Lynch H, Wiesner G, Ferguson K, Eng C, Park JG, Kim SJ, Markowitz S. Grady WM, et al. Nat Genet. 2000 Sep;26(1):16-7. doi: 10.1038/79120. Nat Genet. 2000. PMID: 10973239

10

Transforming growth factor-beta-induced growth inhibition in a Smad4 mutant colon adenoma cell line.

Fink SP, Swinler SE, Lutterbaugh JD, Massagué J, Thiagalingam S, Kinzler KW, Vogelstein B, Willson JK, Markowitz S. Fink SP, et al. Cancer Res. 2001 Jan 1;61(1):256-60. Cancer Res. 2001. PMID: 11196171

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

268 results

Search Page